ReveraGen Receives $3.3M NIH Grant to Advance Vamorolone in DMD
News
ReveraGen BioPharma has been awarded a $3.3 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH) to support further ... Read more